phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with neuropeptide y in 6 studies
Studies (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Trials (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Studies (neuropeptide y) | Trials (neuropeptide y) | Recent Studies (post-2010) (neuropeptide y) |
---|---|---|---|---|---|
276 | 0 | 55 | 10,663 | 152 | 2,269 |
Protein | Taxonomy | phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide (IC50) | neuropeptide y (IC50) |
---|---|---|---|
Neuropeptide Y receptor type 1 | Homo sapiens (human) | 0.0014 | |
Neuropeptide Y receptor type 2 | Homo sapiens (human) | 0.0003 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Panula, P; Wasowicz, K | 1 |
Casini, A; D'Este, L; Pontieri, FE; Renda, TG | 1 |
Mollereau, C; Roumy, M; Zajac, JM | 1 |
Miyazaki, R; Yamada, T; Yamamoto, T | 1 |
Bernhardt, G; Biselli, S; Buschauer, A; Cabrele, C; Einsiedel, J; Gmeiner, P; Hübner, H; Keller, M; Kuhn, KK; Mollereau, C; Svobodová, J; Vanderheyden, PM; Wifling, D | 1 |
Bertelsen, CV; Cornea, A; Frazier, SED; Gerstenberg, MK; Guldbrandt, M; Hansen, AMK; John, LM; Lundh, S; Lykkesfeldt, J; Mercer, AJ; Niss, K; Petersen, N; Quintana, CD; Rekling, JC; Torz, L; Villaescusa, JC | 1 |
6 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and neuropeptide y
Article | Year |
---|---|
Distribution of neuropeptide FF in porcine spinal cord in comparison with other neuropeptides and serotonin.
Topics: Animals; Enkephalin, Methionine; Female; Immunohistochemistry; Neuropeptide Y; Neuropeptides; Oligopeptides; Serotonin; Spinal Cord; Substance P; Swine; Thyrotropin-Releasing Hormone | 1994 |
Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment.
Topics: Animals; Brain; Brain Chemistry; Disease Models, Animal; Heroin; Heroin Dependence; Hypothalamo-Hypophyseal System; Immunohistochemistry; Male; Midline Thalamic Nuclei; Narcotics; Neuropeptide Y; Oligopeptides; Pituitary Gland; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Septal Nuclei; Solitary Nucleus | 2006 |
Staurosporine differentiation of NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells induces selectivity of NPFF activity towards opioid receptors.
Topics: Calcium; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Clonidine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Humans; Neuroblastoma; Neuropeptide Y; Oligopeptides; Receptors, Neuropeptide; Receptors, Opioid; Staurosporine | 2007 |
Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Anxiety Agents; Arginine; Formaldehyde; Hot Temperature; Injections, Intraventricular; Male; Narcotic Antagonists; Neuropeptide Y; Neuropeptides; Oligopeptides; Pain; Pain Measurement; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, G-Protein-Coupled; Spinal Cord | 2009 |
Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
Topics: Angiotensin II; Arginine; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Neuropeptide Y; Neurotensin; Oligopeptides; Peptide Fragments; Receptors, Angiotensin; Receptors, Neuropeptide; Receptors, Neurotensin; Structure-Activity Relationship | 2016 |
NPFF Decreases Activity of Human Arcuate NPY Neurons: A Study in Embryonic-Stem-Cell-Derived Model.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Humans; Neurons; Neuropeptide Y; Obesity; Oligopeptides | 2022 |